Marco Montagna

829 total citations
13 papers, 170 citations indexed

About

Marco Montagna is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmacology and Genetics. According to data from OpenAlex, Marco Montagna has authored 13 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Pharmacology and 2 papers in Genetics. Recurrent topics in Marco Montagna's work include Chronic Lymphocytic Leukemia Research (2 papers), Retinal and Optic Conditions (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Marco Montagna is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Retinal and Optic Conditions (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Marco Montagna collaborates with scholars based in Italy, Japan and United Kingdom. Marco Montagna's co-authors include Mario Regazzi, Maria Antonietta Avanzini, Renato Fanin, Maurízio Battaglia Parodi, Francesco Bandello, Monica Bocchia, Miriam Isola, Francesca Patriarca, Francesco Zaja and Francesco Romano and has published in prestigious journals such as Journal of Medical Internet Research, Medicine and Haematologica.

In The Last Decade

Marco Montagna

12 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Montagna Italy	7	64	39	38	32	32	13	170
Jibran Durrani United States	8	70 1.1×	32 0.8×	13 0.3×	13 0.4×	30 0.9×	24	146
Noriyuki Yamakawa Japan	9	33 0.5×	26 0.7×	35 0.9×	18 0.6×	24 0.8×	13	212
Tamami Yoshitama Japan	8	61 1.0×	41 1.1×	26 0.7×	8 0.3×	40 1.3×	16	204
Bettina Bannert Switzerland	7	22 0.3×	21 0.5×	22 0.6×	9 0.3×	35 1.1×	13	158
Robert Greiner United States	5	65 1.0×	47 1.2×	19 0.5×	31 1.0×	92 2.9×	22	218
Asu Fergün Yılmaz Türkiye	5	103 1.6×	40 1.0×	22 0.6×	8 0.3×	19 0.6×	20	147
Fabio De Gennaro Italy	8	42 0.7×	14 0.4×	25 0.7×	14 0.4×	36 1.1×	10	165
Hanxiao You China	7	28 0.4×	15 0.4×	51 1.3×	10 0.3×	63 2.0×	21	217
Jessica Neely United States	10	72 1.1×	16 0.4×	25 0.7×	14 0.4×	57 1.8×	15	206
Suguru Honda Japan	8	29 0.5×	32 0.8×	35 0.9×	5 0.2×	22 0.7×	14	170

Countries citing papers authored by Marco Montagna

Since Specialization

Citations

This map shows the geographic impact of Marco Montagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Montagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Montagna more than expected).

Fields of papers citing papers by Marco Montagna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Montagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Montagna. The network helps show where Marco Montagna may publish in the future.

Co-authorship network of co-authors of Marco Montagna

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Montagna. A scholar is included among the top collaborators of Marco Montagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Montagna. Marco Montagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pietrantonio, Filomena, Marco Montagna, Francesco Rosiello, et al.. (2025). Advancing Toward P6 Medicine: Recommendations for Integrating Artificial Intelligence in Internal Medicine. Clinics and Practice. 15(11). 200–200.

Montagna, Marco, et al.. (2024). Impact of Clinical Decision Support Systems on Medical Students’ Case-Solving Performance: Comparison Study with a Focus Group. JMIR Medical Education. 11. e55709–e55709. 2 indexed citations

Han, Jing, Marco Montagna, Andreas Grammenos, et al.. (2023). Evaluating Listening Performance for COVID-19 Detection by Clinicians and Machine Learning: Comparative Study. Journal of Medical Internet Research. 25. e44804–e44804. 3 indexed citations

Montagna, Marco, et al.. (2023). Trimethoprim-sulfamethoxazole induced aseptic meningitis case report. Medicine. 102(1). e32475–e32475. 1 indexed citations

Lorenzo, Rebecca De, Marco Montagna, Eleonora Bossi, et al.. (2022). A Pilot Study of the Efficacy and Economical Sustainability of Acute Coronavirus Disease 2019 Patient Management in an Outpatient Setting. Frontiers in Medicine. 9. 892962–892962. 1 indexed citations

Notaro, Paolo, et al.. (2021). Chronic, acute and acute-on-chronic pain prevalence in a tertiary care hospital setting.. PubMed. 25(10). 3848–3858. 6 indexed citations

Parodi, Maurízio Battaglia, Francesco Romano, Marco Montagna, et al.. (2018). Choroidal Neovascularization in Torpedo Maculopathy Assessed on Optical Coherence Tomography Angiography. Ophthalmic surgery, lasers & imaging retina. 49(11). e210–e213. 8 indexed citations

Parodi, Maurízio Battaglia, Francesco Romano, Marco Montagna, & Francesco Bandello. (2017). Large choroidal excavation in a patient with rubella retinopathy. European Journal of Ophthalmology. 28(2). 251–252. 10 indexed citations

Ciresa, M., Anna Maria De Gaetano, Maurizio Pompili, et al.. (2015). Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features.. PubMed. 19(15). 2786–97. 30 indexed citations

10.

Montagna, Marco, Marco Montillo, Maria Antonietta Avanzini, et al.. (2011). Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia. Haematologica. 96(6). 932–936. 18 indexed citations

11.

Zaja, Francesco, Marta Lisa Battista, Marco Montagna, et al.. (2008). Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Haematologica. 93(6). 930–933. 78 indexed citations

12.

Montagna, Marco, Maria Antonietta Avanzini, Livia Visai, et al.. (2007). A New Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) for Alemtuzumab Determination: Development, Validation and Application. International Journal of Immunopathology and Pharmacology. 20(2). 363–371. 7 indexed citations

13.

Regazzi, Mario, et al.. (2001). Nelfinavir Suspension Obtained from Nelfinavir Tablets Has Equivalent Pharmacokinetic Profile. Journal of Chemotherapy. 13(5). 569–574. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact